Katrina Thornber, Author at European Medical Journal - Page 41 of 50

Researchers Reveal the Symptoms of Long COVID are Caused by Brainstem Damage

New research using advanced 7T MRI has uncovered microscopic abnormalities in the brainstem of long COVID patients, revealing inflammation up to 18 months post-infection

Genetic Risk of Hidradenitis Suppurativa Linked to Cardiometabolic Disease

A cohort study has examined whether an increased genetic risk of hidradenitis suppurativa is linked to a higher likelihood of developing cardiometabolic diseases.

Primary Ovarian Insufficiency Linked to Increased Multimorbidity

Recent data from the Canadian Longitudinal Study on Aging has highlighted the significant link between primary ovarian insufficiency (POI) and multimorbidity.

Key Predictors of Testosterone Recovery After Prostate Cancer Treatment

A study has provided new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for prostate cancer.

Genetic Mutations Linked to Early Menopause

Four genes with significant effects on the timing of menopause have been uncovered by a recent study offering insights into reproductive aging and cancer risks

Blood Cancer Not Linked to Cognitive Decline in Older Adults

Older adults diagnosed with hematologic malignant neoplasms experience cognitive decline at a rate similar to normal aging.

The Burden of Incorrect Cancer Diagnosis

Prostate cancer is the second leading cause of cancer death worldwide among men, yet recent research suggests many early-stage prostate changes may not require a cancer diagnosis.

Predicting Progression of Barrett's Oesophagus with Genomic Markers – UEG Week 2024

At UEG Week 2024, researchers showed that TP53 mutations and chromosomal changes improve prediction of oesophageal adenocarcinoma in low-risk Barrett’s oesophagus.

COVID-19 Linked to Increased Risk of Stroke

A new meta-analysis has revealed a significant association between COVID-19 and an increased risk of stroke, suggesting that the virus should be considered as a new risk factor for cerebrovascular diseases

How Effective is Influenza Vaccination in Young Children?

A recent study has evaluated the effectiveness of influenza vaccines in children aged 6–59 months in Spain during the 2023–2024 flu season, following the first national recommendation for this age group to receive vaccination